Processing of kaliuretic peptide in human plasma and serum

Peptides

Volumn 17, Issue 6, 1996, Pages 1041-1046

  Overton, Rose M ^a   Vesely, David L ^a,b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

high performance gel permeation chromatography; kaliuretic peptide; metabolic degradation; plasma; serum

Indexed keywords

ARTICLE; BLOOD; CONTROLLED STUDY; GEL PERMEATION CHROMATOGRAPHY; HORMONE METABOLISM; HUMAN; HUMAN TISSUE; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0029963394     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/0196-9781(96)00135-0     Document Type: Article

References (20)

1. 1. Barr, P. J. Mammalian subtilisins: the long-sought dibasic processing endoproteases. Cell 66:1-3; 1991.
2. + -ATPase of the atrial natriuretic peptides. Endocrinology 136:2033-2039; 1995.
3. 3. Gower, W. R., Jr.; Chiou, S.; Skolnick, K.; Vesely, D. L. Molecular forms of circulating atrial natriuretic peptides in human plasma and their metabolites. Peptides 15:861-867; 1994.
4. 4. Gros, C.; Souque, A.; Schwartz, J. C. Degradation of atrial natriuretic factor in mouse blood in vitro and in vivo: Role of enkephalinase (EC 3.4.24.11). Peptides 17:1-5; 1990.
5. 5. Koehn, J. A.; Norman, J. A.; Jones, B. N.; Lesueur, L.; Sakane, Y.; Ghai, R. D. Degradation of atrial natriuretic factor by kidney cortex membrane. J. Biol. Chem. 262:11623-11627; 1987.
6. 2-terminus are natriuretic and/or kaliuretic. Am. J. Physiol. 258:F1401-F1408; 1990.
7. 7. Olins, G. M.; Spear, K. L.; Siegel, N. R.; Zurcher-Neely, H. A. Inactivation of atrial natriuretic factor by the renal brush border. Biochim. Biophys. Acta 901:97-100; 1987.
8. 8. Seidah, N. G.; Chrétien, M.; Day, R. The family of subtilisin/kexin like pro-protein and pro-hormone convertases: Divergent or shared functions. Biochimie 76:197-209; 1994.
9. 9. Van de Ven, W. J. M.; Roebroek, A. J. M.; Van Duijnhoven, H. L. P. Structure and function of eukaryotic proprotein processing enzymes of the subtilisin family of serine proteases. Crit. Rev. Oncogenesis 4(2):115-136; 1993.
10. 10. Vesely, D. L. Atrial natriuretic hormones. Englewood Cliffs, NJ: Prentice Hall, Inc.; 1992.
11. 11. Vesely, D. L. Atrial natriuretic hormones originating from the N-terminus of the atrial natriuretic factor prohormone. Clin. Exp. Pharmacol. Physiol. 22:108-114; 1995.
12. 12. Vesely, D. L.; Chiou, S.; Douglas, M. A.; McCormick, M. T.; Rodriguez-Paz, G.; Schocken, D. D. Kaliuretic peptide and long acting natriuretic peptide as well as atrial natriuretic factor inhibit aldosterone secretion. J. Endocrinol. 146:383-380; 1995.
13. 13. Vesely, D. L.; Douglass, M. A.; Dietz, J. R.; Giordano, A. T.; McCormick, M. T.; Rodriguez-Paz, G.; Schocken, D. D. Prohormone atrial natriuretic peptide 79-98 (kaliuretic stimulator) lowers blood pressure and increases potassium excretion. Circulation 88:I331; 1993.
14. 14. Vesely, D. L.; Douglass, M. A.; Dietz, J. R.; Giordano, A. T.; McCormick, M. T.; Rodriguez-Paz, G.; Schocken, D. D. Negative feedback of atrial natriuretic peptides. J. Clin. Endocrinol. Metab. 78:1128-1134; 1994.
15. 15. Vesely, D. L.; Douglass, M. A.; Dietz, J. R.; Gower, W. R., Jr.; McCormick, M. T.; Rodriguez-Paz, G.; Schocken, D. D. Three peptides from the atrial natriuretic factor prohormone amino terminus lower blood pressure and produce a diuresis, natriuresis, and/or kaliuresis in humans. Circulation 90:1129-1140; 1994.
16. 16. Vesely, D. L.; Giordano, A. T. Food intake and body positional change alter the circadian rhythm of atrial natriuretic peptides excretion into human urine. Chronobiol. Int. 8:373-384; 1991.
17. 17. Vesely, D. L.; Gower, W. R., Jr.; Giordano, A. T. Atrial natriuretic peptides throughout the plant kingdom: Enhancement of solute flow by peptides from the N-terminus of the atrial natriuretic factor prohormone. Am. J. Physiol. 265:E465-E477; 1993.
18. 18. Vesely, D. L.; Norsk, P.; Gower, W. R., Jr.; Chiou, S.; Epstein, M. Release of kaliuretic peptide during immersion-induced central hypervolemia in healthy humans. Proc. Soc. Exp. Biol. Med. 209:20-26; 1995.
19. 19. Vesely, D. L.; Preston, R.; Gower, W. R., Jr.; Chiou, S.; Epstein, M. Increased release of kaliuretic peptide during immersion-induced central hypervolemia in cirrhotic humans. Am. J. Nephrol. 16:128-137; 1996.
20. 20. Yandle, T. G.; Espiner, E. A.; Nicholls, M. G.; Duff, H. Radioimmunoassay and characterization of atrial natriuretic peptide in human plasma. J. Clin. Endocrinol. Metab. 63:72-79; 1986.